Overview

Ictal and Interictal Inflammatory Markers in Migraine

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate blood levels of several proteins that may be altered in the inflammation associated with migraine headaches. These blood levels will be evaluated in individuals during an acute migraine attack and compared to their levels when pain free. The investigators study hypothesis is that the pro inflammatory proteins in the blood will be greater than the levels of these proteins when evaluated during a pain free period.
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
The Cleveland Clinic
University of Toledo Health Science Campus
Treatments:
Naproxen
Prochlorperazine
Sumatriptan